5-(4-(3-Methoxyphenyl)piperazin-1-yl)pyrimidine-2,4-diamine

ID: ALA4546142

Chembl Id: CHEMBL4546142

PubChem CID: 155553663

Max Phase: Preclinical

Molecular Formula: C15H20N6O

Molecular Weight: 300.37

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cccc(N2CCN(c3cnc(N)nc3N)CC2)c1

Standard InChI:  InChI=1S/C15H20N6O/c1-22-12-4-2-3-11(9-12)20-5-7-21(8-6-20)13-10-18-15(17)19-14(13)16/h2-4,9-10H,5-8H2,1H3,(H4,16,17,18,19)

Standard InChI Key:  HAMIUMQPXQROCP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4546142

    ---

Associated Targets(Human)

DHFR Tclin Dihydrofolate reductase (3072 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Dihydrofolate reductase (1637 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 300.37Molecular Weight (Monoisotopic): 300.1699AlogP: 0.98#Rotatable Bonds: 3
Polar Surface Area: 93.53Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.50CX LogP: 1.35CX LogD: 1.02
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.87Np Likeness Score: -1.10

References

1. Hopper AT, Brockman A, Wise A, Gould J, Barks J, Radke JB, Sibley LD, Zou Y, Thomas S..  (2019)  Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis.,  62  (3): [PMID:30624926] [10.1021/acs.jmedchem.8b01754]

Source